Acid‐Responsive Aggregated Gold Nanoparticles for Radiosensitization and Synergistic Chemoradiotherapy in the Treatment of Esophageal Cancer-Reference-Cited by-同舟云学术

Acid‐Responsive Aggregated Gold Nanoparticles for Radiosensitization and Synergistic Chemoradiotherapy in the Treatment of Esophageal Cancer

Published:2022-03-09 Issue:19 Volume:18 Page:2200115
ISSN:1613-6810
Container-title:Small
language:en
Short-container-title:Small

Author:

Luan Siyuan¹,Xie Rou²,Yang Yushang¹,Xiao Xin¹,Zhou Jianfeng¹,Li Xiaokun¹,Fang Pinhao¹,Zeng Xiaoxi³,Yu Xiangrong⁴,Chen Meiwan⁵,Gao Huile²^ORCID,Yuan Yong¹

Affiliation:

1. Department of Thoracic Surgery West China Hospital Sichuan University Chengdu 610041 P. R. China

2. Key Laboratory of Drug‐Targeting and Drug Delivery System of the Education Ministry Sichuan Engineering Laboratory for Plant‐Sourced Drug and Sichuan Research Center for Drug Precision Industrial Technology West China School of Pharmacy Sichuan University Chengdu 610041 P. R. China

3. West China Biomedical Big Data Center West China Hospital Sichuan University Chengdu 610041 P. R. China

4. Department of Radiology Zhuhai People's Hospital Jinan University Zhuhai 519000 P. R. China

5. State Key Laboratory of Quality Research in Chinese Medicine Institute of Chinese Medical Sciences University of Macau Macau 999078 P. R. China

Funder

National Natural Science Foundation of China

West China Hospital, Sichuan University

Publisher

Wiley

Subject

Biomaterials,Biotechnology,General Materials Science,General Chemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/smll.202200115

Reference56 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2. Cancer statistics in China, 2015

3. Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer

4. Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial

5. Neoadjuvant Chemoradiotherapy Followed by Surgery Versus Surgery Alone for Locally Advanced Squamous Cell Carcinoma of the Esophagus (NEOCRTEC5010): A Phase III Multicenter, Randomized, Open-Label Clinical Trial

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An acid-activatable fluorouracil prodrug for colorectal cancer synergistic therapy;Acta Biomaterialia;2024-09

2. The prognostic value of controlling nutritional status score on esophageal squamous cell carcinoma patients with neoadjuvant therapy followed by esophagectomy—a retrospective research;Journal of Thoracic Disease;2024-07

3. ⁸⁹Zr-Labeled pH-Responsive Gold Nanoclusters for Radiosensitization Therapy of Tumors;ACS Applied Nano Materials;2024-06-21

4. Substitute or coexistence? Mediastinoscopy-assisted versus thoracoscope-assisted esophagectomy in esophageal cancer: a meta-analysis of perioperative outcomes and long-term survival;International Journal of Surgery;2024-06-13

5. Targeting hypoxic and acidic tumor microenvironment by nanoparticles: A review;Journal of Drug Delivery Science and Technology;2024-06